This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Wen, Y. Articles by Hung, M.-C. Search for Related Content PubMed PubMed Citation Articles by Wen, Y. Articles by Hung, M.-C.

p202, an Interferon-inducible Protein, Mediates Multiple Antitumor Activities in Human Pancreatic Cancer Xenograft Models¹

Departments of Molecular and Cellular Oncology [Y. W., D-H. Y., B. S., Y. D., R. S., Y. Z., M-C. H.], Surgical Oncology [D-H. Y., M-C. H.], Gastrointestinal Medical Oncology [B. W., K. X.], The University of Texas, M. D. Anderson Cancer Center, Houston, Texas 77030

p202, an IFN-inducible protein, interacts with certain transcriptional activators leading to transcriptional repression. p202 expression has been associated with inhibition of cancer cell growth in vitro and in vivo. To examine a potential p202-mediated antitumor activity in pancreatic cancer, we used both ectopic and orthotopic xenograft models and demonstrated that p202 expression is associated with multiple antitumor activities that include inhibition of tumor growth, reduced tumorigenicity, prolonged survival, and remarkably, suppression of metastasis and angiogenesis. In vitro invasion assay also showed that p202-expressing pancreatic cancer cells are less invasive than those without p202 expression. That observation was supported by the findings that p202-expressing tumors showed reduced expression of angiogenic markers, such as interleukin 8 and vascular endothelial growth factor, and p202-expressing pancreatic cancer cells have reduced level of matrix metalloproteinase-2 activity, a secreted protease activity important for metastasis. Importantly, we demonstrated a treatment efficacy by using p202/SN2 liposome complex in a nude mice xenograft model, suggesting a feasibility of using the p202/SN2 liposome in future preclinical gene therapy experiments. Together, our results strongly suggest that p202 expression mediates multiple antitumor activities against pancreatic cancer and may provide a scientific basis for developing a p202-based gene therapy in pancreatic cancer treatment.

This article has been cited by other articles:

				S. Ma, Y. Yang, C. Wang, N. Hui, L. Gu, H. Zhong, Z. Cai, Q. Wang, Q. Zhang, N. Li, et al. Endogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest and Apoptosis through Down-regulation of the Phosphatidylinositide 3-Kinase/Akt/HDM2 Pathway J. Biol. Chem., September 11, 2009; 284(37): 24773 - 24782. [Abstract] [Full Text] [PDF]

				C. Wang, N. Li, X. Liu, Y. Zheng, and X. Cao A Novel Endogenous Human CaMKII Inhibitory Protein Suppresses Tumor Growth by Inducing Cell Cycle Arrest via p27 Stabilization J. Biol. Chem., April 25, 2008; 283(17): 11565 - 11574. [Abstract] [Full Text] [PDF]

				P. Chaturvedi, A. P. Singh, N. Moniaux, S. Senapati, S. Chakraborty, J. L. Meza, and S. K. Batra MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins Mol. Cancer Res., April 1, 2007; 5(4): 309 - 320. [Abstract] [Full Text] [PDF]

				Y. Ding, J.-F. Lee, H. Lu, M.-H. Lee, and D.-H. Yan Interferon-Inducible Protein IFIX{alpha}1 Functions as a Negative Regulator of HDM2. Mol. Cell. Biol., March 1, 2006; 26(5): 1979 - 1996. [Abstract] [Full Text] [PDF]

				I-F. Chen, F. Ou-Yang, J.-Y. Hung, J.-C. Liu, H. Wang, S.-C. Wang, M.-F. Hou, G. N. Hortobagyi, and M.-C. Hung AIM2 suppresses human breast cancer cell proliferation in vitro and mammary tumor growth in a mouse model Mol. Cancer Ther., January 1, 2006; 5(1): 1 - 7. [Abstract] [Full Text] [PDF]

				R. Shao, D.-F. Lee, Y. Wen, Y. Ding, W. Xia, B. Ping, H. Yagita, B. Spohn, and M.-C. Hung E1A Sensitizes Cancer Cells to TRAIL-Induced Apoptosis through Enhancement of Caspase Activation Mol. Cancer Res., April 1, 2005; 3(4): 219 - 226. [Abstract] [Full Text] [PDF]

				R. Qi, H. An, Y. Yu, M. Zhang, S. Liu, H. Xu, Z. Guo, T. Cheng, and X. Cao Notch1 Signaling Inhibits Growth of Human Hepatocellular Carcinoma through Induction of Cell Cycle Arrest and Apoptosis Cancer Res., December 1, 2003; 63(23): 8323 - 8329. [Abstract] [Full Text] [PDF]

				Y. Ding, Y. Wen, B. Spohn, L. Wang, W. Xia, K. Y. Kwong, R. Shao, Z. Li, G. N. Hortobagyi, M.-C. Hung, et al. Proapoptotic and Antitumor Activities of Adenovirus-mediated p202 Gene Transfer Clin. Cancer Res., October 1, 2002; 8(10): 3290 - 3297. [Abstract] [Full Text] [PDF]

				X. Ma, J. Hu, D. J. Lindner, and D. V. Kalvakolanu Mutational Analysis of Human Thioredoxin Reductase 1. EFFECTS ON p53-MEDIATED GENE EXPRESSION AND INTERFERON AND RETINOIC ACID-INDUCED CELL DEATH J. Biol. Chem., June 14, 2002; 277(25): 22460 - 22468. [Abstract] [Full Text] [PDF]

				C. A. Iacobuzio-Donahue, A. Maitra, G. L. Shen-Ong, T. van Heek, R. Ashfaq, R. Meyer, K. Walter, K. Berg, M. A. Hollingsworth, J. L. Cameron, et al. Discovery of Novel Tumor Markers of Pancreatic Cancer using Global Gene Expression Technology Am. J. Pathol., April 1, 2002; 160(4): 1239 - 1249. [Abstract] [Full Text] [PDF]